Medpace Holdings (NASDAQ: MEDP) reported Q2 EPS of $1.93, $0.03 better than the analyst estimate of $1.90. Revenue for the quarter came in at $460.9 million versus the consensus estimate of $433.75 million.

GUIDANCE:

Medpace Holdings sees FY2023 revenue of $1.840-1.880 million, versus the consensus of $1.776 million.

For earnings history and earnings-related data on Medpace Holdings (MEDP) click here.